We just received data on a new analyst forecast for $DOC. Richard Hill from Morgan Stanley set a price target of 20.0 for DOC.
To track analyst ratings and price targets for $DOC, check out Quiver Quantitative's $DOC forecast page.
Should you buy $DOC?
Some analysts are better than others. To view the past performance of Morgan Stanley, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$DOC Price Targets
Multiple analysts have issued price targets for $DOC recently. We have seen 9 analysts offer price targets for $DOC in the last 6 months, with a median target of $19.0.
Here are some recent targets:
- Richard Hill from Morgan Stanley set a target price of $20.0 on 05/22/2026
- Michael Carroll from RBC Capital set a target price of $21.0 on 05/14/2026
- Amanda Sweitzer from Baird set a target price of $21.0 on 05/13/2026
- An analyst from UBS set a target price of $19.0 on 05/13/2026
- Nick Joseph from Citigroup set a target price of $20.0 on 05/12/2026
- James Kammert from Evercore ISI Group set a target price of $19.0 on 02/04/2026
- John Kilichowski from Wells Fargo set a target price of $18.0 on 02/02/2026
$DOC Insider Trading Activity
$DOC insiders have traded $DOC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOC stock by insiders over the last 6 months:
- SCOTT R BOHN (CDO and Head of Lab) sold 10,989 shares for an estimated $213,740
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$DOC Revenue
$DOC had revenues of $753M in Q1 2026. This is an increase of 7.12% from the same period in the prior year.
You can track DOC financials on Quiver Quantitative's DOC stock page.
You can access data on DOC stock through the Quiver Quantitative API.
$DOC Congressional Stock Trading
Members of Congress have traded $DOC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOC stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$DOC Hedge Fund Activity
We have seen 406 institutional investors add shares of $DOC stock to their portfolio, and 371 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CENTERSQUARE INVESTMENT MANAGEMENT LLC removed 8,901,289 shares (-63.0%) from their portfolio in Q4 2025, for an estimated $143,132,727
- PRINCIPAL FINANCIAL GROUP INC removed 7,916,128 shares (-29.7%) from their portfolio in Q1 2026, for an estimated $130,061,983
- BANK OF NEW YORK MELLON CORP added 5,815,189 shares (+60.3%) to their portfolio in Q1 2026, for an estimated $95,543,555
- ALYESKA INVESTMENT GROUP, L.P. added 5,616,667 shares (+inf%) to their portfolio in Q1 2026, for an estimated $92,281,838
- GEODE CAPITAL MANAGEMENT, LLC added 4,866,845 shares (+24.9%) to their portfolio in Q1 2026, for an estimated $79,962,263
- CITADEL ADVISORS LLC removed 4,510,650 shares (-95.9%) from their portfolio in Q1 2026, for an estimated $74,109,979
- FRANKLIN RESOURCES INC added 4,226,342 shares (+1487.1%) to their portfolio in Q1 2026, for an estimated $69,438,799
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
